MRX1 Successfully Delivered to Clinical Trial Site
LONDON, July 6, 2026 /PRNewswire/ -- Ananda Pharma Limited is a UK based bio pharmaceutical company developing regulatory approved cannabidiol medicines to treat complex, chronic conditions. The directors announce the MRX1 investigational product manufactured in 2025 has been delivered to...
LONDON, July 6, 2026 /PRNewswire/ -- Ananda Pharma Limited is a UK based bio pharmaceutical company developing regulatory approved cannabidiol medicines to treat complex, chronic conditions. The directors announce the MRX1 investigational product manufactured in 2025 has been delivered to...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.